The opinion in support of the decision being entered today was not written
for publication and is not binding precedent of the Board.
Paper No. 50
UNITED STATES PATENT AND TRADEMARK OFFICE
__________
BEFORE THE BOARD OF PATENT APPEALS
AND INTERFERENCES
__________
Ex parte D. CLARK BENNETT,
ELIZABETH CAUCHON,
DOMINIQUE FINK,
BRIGETTE GROUIX, and
JOSEPH ZIMMERMANN
Appeal No. 2003-1678
Application No. 08/722,659
__________
ON BRIEF
__________
WINTERS, MILLS, and GREEN, Administrative Patent Judges.
WINTERS, Administrative Patent Judge.
DECISION ON APPEAL
This is a decision under 35 U.S.C. § 134 from the final rejection of claims 1
through 7, 18, and 19, all the claims remaining in the application. Claim 1 is
representative of the subject matter on appeal and reads as follows:
1. A method to decrease localized inflammatory responses arising from an
ischemia/reperfusion injury in a tissue of a patient comprising intravascularly
administering to said patient heparinase enzyme in an effective amount sufficient to
decrease neutrophil transmigration through activated endothelium and basement
membrane of said vasculature which decreases said localized inflammatory response
arising from an ischemia/reperfusion injury.
The reference relied upon by the examiner is:
Page: 1 2 3 4 5 6 7 8 9 10 11 Next
Last modified: November 3, 2007